However, many of the published compounds feature substituents that could be classified as vulnerable to metabolism, or that would confer unwanted lipophilicity on the final target molecule—both properties likely to be deleterious to a therapeutic agent. In the context of a drug discovery programme we wished to prepare analogues of 1 with more metabolically robust substituents. It was found necessary to employ a diverse set of synthetic strategies to achieve this aim—the first of ...
